The Feasibility of Recovered Warm Ischemic Injury on Non-heart-beating Donor Liver by Hepatocyte Growth Factor in Animal Model.
- Author:
Kwang Yong KIM
1
;
Jae Pil JUNG
;
Hea Nam HONG
;
Guang LI
;
You Jin WON
;
Ji Wung CHO
;
Byung Chun KIM
;
Bong Wha CHUNG
;
Kyung Suk CHUNG
;
Jang Yeong JEON
;
Sung Gyu LEE
Author Information
1. Department of Surgery, College of Medicine, Hallym University, Seoul, Korea. powerjung7@medimail.co.kr
- Publication Type:Original Article
- Keywords:
Non-heart-beating donor (NHBD);
Warm ischemic time;
Hepatocyte growth factor (HGF)
- MeSH:
Animals;
Blotting, Western;
Carcinoma, Hepatocellular;
Diminazene;
Hepatocyte Growth Factor;
Hepatocytes;
Humans;
Hypertrophy;
Immunohistochemistry;
Liver;
Liver Failure;
Liver Regeneration;
Liver Transplantation;
Male;
Models, Animal;
Perfusion;
Phosphorylation;
Postoperative Complications;
Rats;
Regeneration;
Risk Factors;
Spine;
Tissue Donors;
Transplants;
Trypan Blue;
Warm Ischemia
- From:The Journal of the Korean Society for Transplantation
2008;22(1):29-40
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Liver transplantation is the therapy of choice for patients with acute and acute-on-chronic severe liver failure or hepatocellular carcinoma. But a suitable liver is not always available for transplantation due to limited donor numbers. To increase the number of available liver for transplantation, a non-heart-beating donor (NHBD) liver transplant program is started. In NHBD liver transplantation, warm ischemic injury of liver occurs. The duration of warm ischemia is thought to be the most important risk factor for postoperative complications such as primary nonfunction or severe hepatic dysfunction. Recent evidence indicates that hepatocyte growth factor (HGF) plays an important role as a cytoprotector against hepatic injury by anti-apoptotic effect and mitogen in liver regeneration. Therefore studies also were performed to examine whether HGF influenced the viability and regeneration of hepatocytes from rats, subjected to prolonged warm ischemic injury. METHODS: Male Sprague- Dawley rats were subjected to non-heart-beating death by cervical spine fracture. Rats left in room temperature directly after, 30-minutes, 1-hours before surgery and perfusion was performed for isolating hepatocyte. Among three groups, hepatocyte viability was compared by trypan blue stain. And isolated hepatocytes from 30-minutes warm ischemic group were cultured for 24-hours, which were treated with no HGF and addition of various doses (5 ng/mL, 10 ng/mL, 20 ng/ mL, 40 ng/mL, 100 ng/mL) of HGF. Anti-apoptosis and regeneration of hepatocyte were compared by LDH assay, MTS assay, western blot, and immunocyto-chemistry after a 24-hours culture. RESULTS: The results of hepatocyte viability along the prolonged warm ischemic groups in isolated hepatocytes decreased sequentially 74.8+/-12.6%, 45.0+/-5.4%, 37.8+/-10.4% along directly after, 30-minutes, 1-hours in trypan blue stain (P<0.01). And 24-hour-cultured hepatocytes from 30-minutes warm ischemic group were treated with HGF. The results of LDH assay, MTS assay did not have relation with HGF addition. But the results of western blot and immunocytochemistry shown that HGF doses dependent anti-apoptosis and regeneration of hepatocyte increased. That indicates HGF presumably inhibites apoptotic pathway by phosphorylation. And HGF also makes hepatocyte hypertrophy and albumin synthesis. CONCLUSION: HGF was a potent cytoprotector against hepatic injury by anti- apoptotic effect and mitogen of liver regeneration in NHBD liver animal model. HGF facilitates recovery of the liver from prolong warm ischemic injury. If the more clinical studies and large animal studies are performed, NHBD using liver transplantation will be available with more chances by HGF.
